Matthew D. Hall

Orcid: 0000-0002-8307-8633

According to our database1, Matthew D. Hall authored at least 10 papers between 2010 and 2022.

Collaborative distances:
  • Dijkstra number2 of four.
  • Erdős number3 of four.

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Dataset
Other 

Links

On csauthors.net:

Bibliography

2022
A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research.
J. Chem. Inf. Model., 2022

Discovery of Small-Molecule VapC1 Nuclease Inhibitors by Virtual Screening and Scaffold Hopping from an Atomic Structure Revealing Protein-Protein Interactions with a Native VapB1 Inhibitor.
J. Chem. Inf. Model., 2022

Virtual Screening for the Discovery of Microbiome β-Glucuronidase Inhibitors to Alleviate Cancer Drug Toxicity.
J. Chem. Inf. Model., 2022

Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments.
Briefings Bioinform., 2022

2020
Self-Reconfiguration in Two-Dimensions via Active Subtraction with Modular Robots.
Proceedings of the Robotics: Science and Systems XVI, 2020

2019
Discovery of novel inhibitors of human galactokinase by virtual screening.
J. Comput. Aided Mol. Des., 2019

Spatial Coverage Without Computation.
Proceedings of the International Conference on Robotics and Automation, 2019

2016
<sup>18</sup>F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier.
NeuroImage, 2016

2015
ADME SARfari: comparative genomics of drug metabolizing systems.
Bioinform., 2015

2010
[11C]N-desmethyl-loperamide, a substrate that selectively images P-glycoprotein function, is trapped in lysosomes.
NeuroImage, 2010


  Loading...